neffy: Summary

neffy

Pharmaceutical, biotechnology, allergy treatment, epinephrine delivery

neffy offers a safe, effective, and user-friendly alternative for epinephrine delivery, empowering patients and caregivers to manage allergic emergencies without fear.

neffy is an FDA-approved needle-free epinephrine nasal spray designed to provide a practical and easy-to-use alternative for patients requiring epinephrine delivery. It aims to address the challenges associated with traditional needle-based delivery methods.

Needle-free delivery system; FDA-approved for safety and efficacy; Portable and easy to administer; Co-pay support and patient assistance programs

neffy is most valuable for individuals with severe allergies who require immediate access to epinephrine, caregivers managing allergic reactions, and patients seeking a more convenient delivery method.

Eliminates needle-related risks; Designed for ease of use and portability; Comprehensive support programs for patients

neffy's innovative design and FDA approval provide a reliable and convenient option for patients, while the company's commitment to affordability enhances its accessibility.

neffy positions itself as a modern, patient-friendly solution in the epinephrine delivery market, focusing on safety and ease of use.

The target users include allergy sufferers, parents of children with allergies, and healthcare providers looking for effective treatment options.

Learn More

• epinephrine

• needle-free

• allergy treatment

• patient support

Rethinking Epinephrine Therapy

Innovative, supportive, empowering

neffy is the first and only FDA-approved needle-free epinephrine product, setting it apart from traditional epinephrine delivery methods that require needles.

ARS Pharma is positioned as an innovative biotechnology company dedicated to developing accessible and effective treatments for serious health issues.

2015-01-01

• Richard Lowenthal

• Sarina Tanimoto